Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 30 and 60 years old
- People who have been diagnosed with an insomnia disorder and take more than 30 minutes to fall asleep at least 3 nights per week
- People who are able to understand the goals and risks of the research and can provide written, signed, and dated consent
- People who are covered by a social health insurance scheme
- Women who could become pregnant must be using an effective form of contraception for the duration of the study, such as hormonal contraception or an IUD
Who may not be able to join:
- People who have done shift work in the year before joining the trial
- People who have travelled across more than 2 time zones in the month before joining the trial
- People who are currently in a waiting or exclusion period because of another clinical study
- People for whom it is not possible to obtain proper informed consent (such as those who have difficulty understanding the information)
- People who are under judicial protection
- People who are under legal guardianship or a similar legal arrangement
- Women who are currently pregnant or breastfeeding
- People taking medications that can affect sleep or a specific body clock measurement used in this trial, including steroid medications taken by mouth or injection, beta-blockers taken in the evening, or melatonin supplements
- People who have a condition called delayed sleep phase syndrome (a body clock disorder)
- People who have restless legs syndrome rated as severe based on a standard assessment score
- People with other psychiatric conditions or substance/addiction disorders, as assessed by a structured interview
- People with certain unstabilised medical conditions, including: chronic allergies, neurological disorders, heart or circulation problems, breathing problems, digestive conditions, blood disorders, eye diseases, immune system diseases, kidney or urinary conditions, hormonal or metabolic conditions, infectious diseases, or epilepsy
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Patrice BOURGIN, MD, Hôpitaux Universitaires de Strasbourg
Phone: 03 88 11 64 30
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change Sleep latency
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.